Farmacja Współczesna 2025/4

  • Development and validation of a UPLC MS/MS method for the determination of fenofibric acid, the active metabolite of fenofibrate
    Hanna Urjasz, Viktoriia Propisnova

PDF


  • Therapeutic monoclonal antibodies: new opportunities in nephrology
    Janusz Świeczkowski-Feiz, Aleksandra Maciejczyk, Katarzyna Krupa, Ryszard Gellert

PDF


  • CAR-T in systemic lupus erythematosus treatment
    Artur Cieślewicz, Wei-Wen Huang

PDF


  • Overview of targeted therapies for chronic inflammatory diseases of the gastrointestinal tract used in the Polish Therapeutic Program
    Bartosz Antonik, Maciej Pankowski, Michał Wróbel, Natalia Zenker, Hanna Winnicka-Łysakowska, Kamila Stawczyk-Eder

PDF


  • Acute appendicitis – pathophysiology, diagnosis, and pharmacotherapy with particular emphasis on the pediatric population
    Konrad Sarnowski, Julia Kerner, Antonina Wiland, Zofia Rusche, Paulina Frąckowiak, Danuta Szkutnik-Fiedler

PDF


  • Recommended strategies for monitoring mycophenolic acid concentrations in kidney transplant recipients in the hospital setting – a practical proposal for clinical pharmacists
    Angelika Śmiertka, Łukasz Hońdo, Agnieszka Cios, Anna Wesołowska

PDF


  • Why do some patients take tikagrelor together with acetylsalicylic acid, while others take riwaroksaban?
    Marcin Grabowski

PDF


  • Polio vaccination – a history of discoveries and failures
    Eliza Strugała, Barbara Cieślińska, Aleksandra Piątek, Kamil Krupa, Amelia Lala, Bartosz Laskowski, Piotr Skalski

PDF


  • Oxidative stress in the pathogenesis of liver diseases: mechanisms, consequences, and therapeutic opportunities
    Olga Obrzut, Violetta Krajka-Kuźniak

PDF


  • Somnolence induced by hydroxyzine use. Case report and literature review
    Katarzyna Korzeniowska

PDF


Farmacja okładka_1_2016